D.E. Shaw & Co’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-767,066
| Closed | -$1.75M | – | 3548 |
|
|
2024
Q2 | $1.75M | Sell |
767,066
-18,193
| -2% | -$41.5K | ﹤0.01% | 1886 |
|
|
2024
Q1 | $3.39M | Buy |
785,259
+289,808
| +58% | +$1.25M | ﹤0.01% | 1477 |
|
|
2023
Q4 | $1.51M | Sell |
495,451
-9,631
| -2% | -$29.4K | ﹤0.01% | 1871 |
|
|
2023
Q3 | $727K | Sell |
505,082
-111,421
| -18% | -$160K | ﹤0.01% | 2181 |
|
|
2023
Q2 | $1.54M | Buy |
616,503
+186,864
| +43% | +$465K | ﹤0.01% | 1888 |
|
|
2023
Q1 | $1.15M | Sell |
429,639
-15,068
| -3% | -$40.4K | ﹤0.01% | 2121 |
|
|
2022
Q4 | $2.41M | Buy |
444,707
+349,733
| +368% | +$1.9M | ﹤0.01% | 1931 |
|
|
2022
Q3 | $1.19M | Sell |
94,974
-42,005
| -31% | -$525K | ﹤0.01% | 2461 |
|
|
2022
Q2 | $677K | Buy |
+136,979
| New | +$677K | ﹤0.01% | 2888 |
|
|
2021
Q1 | – | Sell |
-17,465
| Closed | -$314K | – | 3244 |
|
|
2020
Q4 | $314K | Buy |
+17,465
| New | +$314K | ﹤0.01% | 2446 |
|
|
2020
Q2 | – | Sell |
-51,283
| Closed | -$565K | – | 2874 |
|
|
2020
Q1 | $565K | Buy |
+51,283
| New | +$565K | ﹤0.01% | 2098 |
|